Search research articles
Contact Us
Filters
Showing results (181-190 of 217) with videos related to
Page
of 22
Sort By:
Leukemia
|
July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasms
Tristan L Lim, David B Lieberman, Adam R Davis, et al.
American Journal of Hematology
|
April 7, 2020
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study
Heesun J Rogers, Xiaoqiong Wang, Yan Xie, et al.
The New England Journal of Medicine
|
September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Alfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
American Journal of Clinical Pathology
|
April 10, 2024
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study
Genevieve M Crane, Julia T Geyer, Beenu Thakral, et al.
American Journal of Hematology
|
November 23, 2024
Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS-Associated Mutations: A Study From the Bone Marrow Pathology Group
Timothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia
Donald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
American Journal of Hematology
|
October 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group
Timothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Haematologica
|
November 20, 2023
<i>STAT5B</i> mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia
C Cameron Yin, Wayne Tam, Serena M Walker, et al.
Science Translational Medicine
|
September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Haematologica
|
November 8, 2011
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Alejandra Carvajal-Cuenca, Luz F Sua, Nhora M Silva, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 217) with videos related to
Sort By:
Page
of 22
Leukemia
|
July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasms
Tristan L Lim, David B Lieberman, Adam R Davis, et al.
American Journal of Hematology
|
April 7, 2020
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study
Heesun J Rogers, Xiaoqiong Wang, Yan Xie, et al.
The New England Journal of Medicine
|
September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Alfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
American Journal of Clinical Pathology
|
April 10, 2024
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study
Genevieve M Crane, Julia T Geyer, Beenu Thakral, et al.
American Journal of Hematology
|
November 23, 2024
Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS-Associated Mutations: A Study From the Bone Marrow Pathology Group
Timothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia
Donald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
American Journal of Hematology
|
October 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group
Timothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Haematologica
|
November 20, 2023
<i>STAT5B</i> mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia
C Cameron Yin, Wayne Tam, Serena M Walker, et al.
Science Translational Medicine
|
September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Haematologica
|
November 8, 2011
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Alejandra Carvajal-Cuenca, Luz F Sua, Nhora M Silva, et al.
Page
of 22